Management of a high-output postoperative enterocutaneous fistula with a vacuum sealing method and continuous enteral nutrition.
A postoperative enterocutaneous fistula is one of the most complex medical problems. Its treatment may become long-lasting, wearisome, and its outcome often is disappointing. Here, we describe the use of a novel device to treat a 67-year-old patient with a postoperative, high-output enterocutaneous fistula. A semipermeable barrier was created over the fistula by vacuum packing a synthetic, hydrophobic polymer covered with a self-adherent surgical sheet. To set up the system, we constructed a vacuum chamber equipped with precision instruments that supplied subatmospheric pressures between 350 and 450 mm Hg. The intestinal content was, thus, kept inside the lumen, restoring bowel transit and physiology. The fistula output was immediately reduced from a median of 800 ml/day (range, 400-1,600 ml/day), to a median of 10 ml/day (range, 0-250 ml/day), which was readily collected by the apparatus. Oral feeding was reinitiated while both parenteral nutrition and octreotide were withdrawn. No septic complications occurred, and the perifistular skin stayed protected from irritating intestinal effluents. Both the fistula orifice and the wound defect fully healed after 50 days of treatment. We believe this method may serve as a useful tool to treat selected cases of high-output enterocutaneous fistulas without the need for octreotide or parenteral nutrition.
Hyon
S H
SH
Department of Surgery, Hospital Italiano de Buenos Aires, Argentina.
Martinez-Garbino
J A
JA
Benati
M L
ML
Lopez-Avellaneda
M E
ME
Brozzi
N A
NA
Argibay
P F
PF
D000368:Aged; D017577:Cutaneous Fistula / Q000628:therapy*; D004750:Enteral Nutrition; D006801:Humans; D007412:Intestinal Fistula / Q000628:therapy*; D008297:Male; D015282:Octreotide / Q000627:therapeutic use; D010289:Parenteral Nutrition, Total; D011183:Postoperative Complications / Q000628:therapy*
D015282:Octreotide